Still taking it all in—what an honor to highlight some of the most exciting lung cancer research from #ASCO25! Standing at the ASCO podium has been a DREAM of mine. I’m so deeply grateful for this moment & for the chance to represent a community that means everything to me. 🤍

Honored to have our PRE-I-SPY PRE2 trial featured at #ASCO25! Grateful to Dr. #FundaMericBernstam for the spotlight on our work with #Zanidatamab + #Tucatinib #ISPY_Trials #Quantum_Leap #bcsm

Very inspiring talk about the multiple roles played by a woman in oncology. Grateful to be the audience to this. Thank you Rachna Shroff, MD, MS, FASCO Julie Gralow for your encouraging words. #ASCO #WLO

#ASCO25 was packed with astonishing, practice-informing data. Two of the most provocative findings weren’t drugs—but non-pharmacologic interventions that improved outcomes when added to standard therapy: Exercise saves lives. Structured aerobic activity (≥10 MET-hrs/week)

🧵1/ T cells have deservedly been in the🔦for #cancer #immunotherapy, but other engineered cell therapies are now📈. What mediates NK cell exhaustion remains an important unanswered❓. 📄Link: nature.com/articles/s4158… I’m so thrilled🥳to share our work out now🚨nature

📢 New study in JAMA Oncology (Li et al. 2025) compares digital breast tomosynthesis (DBT) vs digital mammography (DM) in >200k women with a family history of breast cancer. ✅ DBT significantly reduced recall rates (fewer patients called back for additional imaging) and increased

Sending a warm welcome to the nearly 300 students joining our 18 immersive MD Anderson Cancer Center CATALYST Summer Training Programs! Over the next 10-weeks, they will gain hands-on, clinical experience while further developing their research skills. Good luck to all!

We’re very proud of our MD Anderson Cancer Center heme/onc fellows Neha Akkad Nazli Dizman Cindy Y. Jiang Jen Marvin-Peek, MD Hila Shaim Inimfon Jackson Paulino Tallón de Lara MD, PhD Ranjan Upadhyay Michael Wotman Jenny Xiang Michael LaPelusa, MD Nakul Shah

What an incredible Evening to Conquer Cancer! Attendees mingled with grant recipients and shared stories of progress in oncology. Honored to celebrate so many dedicated people working to create a world where cancer is prevented or cured, and every survivor is healthy. #ASCO25

In women with node-positive breast cancer whose nodes became free of disease after neoadjuvant therapy, regional nodal irradiation did not reduce breast cancer recurrence or improve survival. Full results from a phase 3 trial: nej.md/4dM6LjD

Thrilled to officially join the 2025–2026 ASCO Trainee & Early Career Advisory Group (ASCO TECAG )! 💼🌟 This powerhouse team brings together trainees from across the country united by a shared mission: championing the next generation of oncologists. Grateful for the

Always a blast to share the stage with the one and only superstar Paolo Tarantino! #DB09 is a game changer—but oncology is still an art. Will we use T-DXd continuously? As induction then maintenance? Rechallenge at progression? With or without pertuzumab? So many unanswered

A lot of exciting data came out of #ASCO25—but some presentations were a sobering wake-up call. As Sonya Reid, MD MPH highlighted, nearly 50% of patients with mTNBC don’t receive any treatment beyond first-line therapy. This is unacceptable. In 2025, this should not be the reality.

✍️Mark your calendar for our next upcoming space‼️ Conquer Conversations; Navigating Career Development with Conquer Cancer Support🏆 Speaker: Julia Schwartz/Conquer Cancer, the ASCO Foundation Host: Noha N. Soror, MD, MSc. 𓂀 ⏰Tuesday, 1st July, 2025 📍Zoom, 17:30 pm EST (Scan QR code for registration)

🤩Preclinical and clinical data on #Ivonescimab in other cancers shows an immense promise for our patients with #KidneyCancer 🙏Thanks Pavlos Msaouel Andy Hahn for your mentorship in developing this protocol #IVORY. ✨Looking forward to enrolling our patients and learning more

Congratulations to the 2025 Sabin Family Fellows — 10 early career researchers selected for their bold, high-impact cancer research. We thank the Sabin Family Fellowship for their continued support. spr.ly/60154Ibll #EndCancer

Thrilled, honored, and humbled to be selected as a new Sabin fellow MD Anderson Cancer Center! Immensely grateful to the Sabin family for their generous support and inspiring vision to advance innovative cancer research and therapies. Congratulations to all the new fellows— excited for the

Inimfon Jackson MD Anderson Cancer Center Thanks so much Ini! You too are 🌟🌟

🤩Click the link below and nominate a #WomenInOncology who inspires you for the #LEAD25 awards! 🎖️2025 Woman Oncologist of the Year 🎖️ 2025 Rising Star awards And join us in Scottsdale, AZ on 9/27-9/28 to celebrate together! 👉 bioascend.com/lead-awards/ Dr. Julie Brahmer

After CDK4/6 Inhibitors: Advancing Treatment for HR+HER2-negative Metastatic Breast Cancer— Mafalda Oliveira, Erica Mayer, and Shom Goel will address this topic in an educational session at #SABCS25 (December 9-12). brnw.ch/21wUjob Mafalda Oliveira Erica Mayer Shom Goel